Next Article in Journal
Antidepressants and Suicide Risk: A Comprehensive Overview
Next Article in Special Issue
Dual Allosteric Effect in Glycine/NMDA Receptor Antagonism: A Comparative QSAR Approach
Previous Article in Journal
Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development
Previous Article in Special Issue
Mechanism of Allosteric Modulation of the Cys-loop Receptors
Open AccessReview

Allosteric Modulation of Muscarinic Acetylcholine Receptors

1
Institute of Physiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 00 Praha, Czech Republic
2
Division of Neuroscience Research in Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55455, USA
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(9), 2838-2860; https://doi.org/10.3390/ph3092838
Received: 8 July 2010 / Revised: 17 August 2010 / Accepted: 18 August 2010 / Published: 30 August 2010
(This article belongs to the Special Issue Allosteric Modulation)
An allosteric modulator is a ligand that binds to an allosteric site on the receptor and changes receptor conformation to produce increase (positive cooperativity) or decrease (negative cooperativity) in the binding or action of an orthosteric agonist (e.g., acetylcholine). Since the identification of gallamine as the first allosteric modulator of muscarinic receptors in 1976, this unique mode of receptor modulation has been intensively studied by many groups. This review summarizes over 30 years of research on the molecular mechanisms of allosteric interactions of drugs with the receptor and for new allosteric modulators of muscarinic receptors with potential therapeutic use. Identification of positive modulators of acetylcholine binding and function that enhance neurotransmission and the discovery of highly selective allosteric modulators are mile-stones on the way to novel therapeutic agents for the treatment of schizophrenia, Alzheimer’s disease and other disorders involving impaired cognitive function. View Full-Text
Keywords: muscarinic acetylcholine receptors; allosteric modulation; Alzheimer’s disease; schizophrenia muscarinic acetylcholine receptors; allosteric modulation; Alzheimer’s disease; schizophrenia
Show Figures

Figure 1

MDPI and ACS Style

Jakubík, J.; El-Fakahany, E.E. Allosteric Modulation of Muscarinic Acetylcholine Receptors. Pharmaceuticals 2010, 3, 2838-2860.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop